| 1 |
31560700 | A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study). | 2019 |
1 |
| 2 |
25929922 | Differential effects of viremia and microbial translocation on immune activation in HIV-infected patients throughout ritonavir-boosted darunavir monotherapy. | 2015 May |
1 |
| 3 |
26679853 | Nuke-Sparing Regimens for the Long-Term Care of HIV Infection. | 2015 Oct-Dec |
1 |
| 4 |
25715484 | [Results of a comparative study of the efficacy of once daily darunavir/atazanavir in treatment-naïve patients with HIV infection]. | 2014 |
2 |
| 5 |
23562640 | A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure. | 2013 Jul |
1 |
| 6 |
24396625 | Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy. | 2013 |
1 |
| 7 |
22549499 | High dose of darunavir in treatment-experienced HIV-infected adolescent results in virologic suppression and improved CD4 cell count. | 2012 Jun |
2 |
| 8 |
21692667 | Darunavir: an effective protease inhibitor for HIV-infected patients. | 2011 Jun |
1 |
| 9 |
21182350 | Predicting direct costs of HIV care during the first year of darunavir-based highly active antiretroviral therapy using CD4 cell counts: evidence from POWER. | 2010 |
2 |
| 10 |
19940948 | First-line boosted protease inhibitor-based regimens in treatment-naive HIV-1-infected patients--making a good thing better. | 2009 Oct-Dec |
1 |
| 11 |
17461851 | Prediction of clinical benefits of ritonavir-boosted TMC114 from treatment effects on CD4 counts and HIV RNA. | 2007 May |
2 |
| 12 |
17621459 | Analysis of treatment costs for HIV RNA reductions and CD4 increases for darunavir versus other antiretrovirals in treatment-experienced, HIV-infected patients. | 2007 May-Jun |
2 |
| 13 |
17803366 | Predicting HIV care costs using CD4 counts from clinical trials. | 2007 Sep |
1 |